|
|
||||||||
AJP - Renal Physiology, Vol 265, Issue 4 561-F568, Copyright © 1993 by American Physiological Society
ARTICLES |
F. A. Gesek
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755.
The influence of alpha-adrenoceptor subtypes on Na+ transport in distal convoluted tubules (DCT) has not been examined due to the difficulty of isolating and quantifying responses in this segment. These experiments were designed to test the hypothesis that alpha-adrenergic receptors stimulate Na+ absorption in DCT cells. Norepinephrine and epinephrine increased 22Na+ uptake into immortalized mouse DCT cells by 49 and 55% compared with basal uptake. Selective alpha 2-agonists (guanabenz, clonidine, and B-HT 933) stimulated 22Na+ uptake by 39-45%, but alpha 1-agonists had no effect. alpha 2-Agonist-stimulated 22Na+ uptake was abolished with alpha 2-antagonists (yohimbine, idazoxan). The entry pathways for alpha 2-agonist-stimulated 22Na+ uptake were determined with the NaCl cotransport inhibitor, chlorothiazide (10(-4) M), and the Na+ channel blocker, amiloride (10(-6) M). Agonist-stimulated 22Na+ uptake was inhibited 42 +/- 5 with chlorothiazide and 47 +/- 7% with amiloride. These results suggested that alpha 2-receptors may activate Na(+)-K(+)-adenosinetriphosphatase (Na(+)-K(+)-ATPase), resulting in an increased driving force for luminal Na+ entry through both pathways. Ouabain-suppressible 86Rb uptake and intracellular Na+ activity ([Na+]i; measured in single cells on glass cover slips loaded with the fluorescent probe sodium-binding benzofuran isophthalate) were used to measure Na(+)-K(+)-ATPase activity. alpha 2-Agonists significantly increased 86Rb uptake within 30 s. After 2.5 min, epinephrine and B-HT 933 decreased [Na+]i from a control level of 13 +/- 1 to 5 +/- 1 mM.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
L.-J. Dai, G. Ritchie, D. Kerstan, H. S. Kang, D. E. C. Cole, and G. A. Quamme Magnesium Transport in the Renal Distal Convoluted Tubule Physiol Rev, January 1, 2001; 81(1): 51 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Reilly and D. H. Ellison Mammalian Distal Tubule: Physiology, Pathophysiology, and Molecular Anatomy Physiol Rev, January 1, 2000; 80(1): 277 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Gesek {alpha}1- and {alpha}2-Adrenoceptor Control of Sodium Transport Reverses in Developing Hypertension Hypertension, January 1, 1999; 33(1): 524 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lockette, K. Kirkland, and S. Farrow {alpha}2-Adrenergic Agonists Increase Cellular Lactate Efflux Hypertension, May 1, 1996; 27(5): 1104 - 1107. [Abstract] [Full Text] |
||||
![]() |
D. E. Handy and H. Gavras Evidence for Cell-Specific Regulation of Transcription of the Rat {alpha}2A-Adrenergic Receptor Gene Hypertension, April 1, 1996; 27(4): 1018 - 1024. [Abstract] [Full Text] |
||||
![]() |
G. Gong, M. L. Johnson, and W. A. Pettinger Testosterone Regulation of Renal {alpha}2B-Adrenergic Receptor mRNA Levels Hypertension, March 1, 1995; 25(3): 350 - 355. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |